10 results on '"Maggie H. Wang"'
Search Results
2. A Bayesian method for synthesizing multiple diagnostic outcomes of COVID-19 tests
- Author
-
Lirong Cao, Shi Zhao, Qi Li, Lowell Ling, William K. K. Wu, Lin Zhang, Jingzhi Lou, Marc K. C. Chong, Zigui Chen, Eliza L. Y. Wong, Benny C. Y. Zee, Matthew T. V. Chan, Paul K. S. Chan, and Maggie H. Wang
- Subjects
COVID-19 ,SARS-CoV-2 ,reverse transcription–polymerase chain reaction ,chest computed tomography ,serological tests ,multiple tests integration ,Science - Abstract
The novel coronavirus disease 2019 (COVID-19) has spread worldwide and threatened human life. Diagnosis is crucial to contain the spread of SARS-CoV-2 infections and save lives. Diagnostic tests for COVID-19 have varying sensitivity and specificity, and the false-negative results would have substantial consequences to patient treatment and pandemic control. To detect all suspected infections, multiple testing is widely used. However, it may be challenging to build an assertion when the testing results are inconsistent. Considering the situation where there is more than one diagnostic outcome for each subject, we proposed a Bayesian probabilistic framework based on the sensitivity and specificity of each diagnostic method to synthesize a posterior probability of being infected by SARS-CoV-2. We demonstrated that the synthesized posterior outcome outperformed each individual testing outcome. A user-friendly web application was developed to implement our analytic framework with free access via http://www2.ccrb.cuhk.edu.hk/statgene/COVID_19/. The web application enables the real-time display of the integrated outcome incorporating two or more tests and calculated based on Bayesian posterior probability. A simulation-based assessment demonstrated higher accuracy and precision of the Bayesian probabilistic model compared with a single-test outcome. The online tool developed in this study can assist physicians in making clinical evaluations by effectively integrating multiple COVID-19 tests.
- Published
- 2021
- Full Text
- View/download PDF
3. Mucosal Antibody Response to SARS-CoV-2 in Paediatric and Adult Patients: A Longitudinal Study
- Author
-
Renee W. Y. Chan, Kate C. C. Chan, Grace C. Y. Lui, Joseph G. S. Tsun, Kathy Y. Y. Chan, Jasmine S. K. Yip, Shaojun Liu, Michelle W. L. Yu, Rita W. Y. Ng, Kelvin K. L. Chong, Maggie H. Wang, Paul K. S. Chan, Albert M. Li, and Hugh Simon Lam
- Subjects
SARS-CoV-2 ,mucosal antibody ,paediatric ,specific IgA ,specific IgG ,Medicine - Abstract
Background: SARS-CoV-2 enters the body through inhalation or self-inoculation to mucosal surfaces. The kinetics of the ocular and nasal mucosal-specific-immunoglobulin A(IgA) responses remain under-studied. Methods: Conjunctival fluid (CF, n = 140) and nasal epithelial lining fluid (NELF, n = 424) obtained by paper strips and plasma (n = 153) were collected longitudinally from SARS-CoV-2 paediatric (n = 34) and adult (n = 47) patients. The SARS-CoV-2 spike protein 1(S1)-specific mucosal antibody levels in COVID-19 patients, from hospital admission to six months post-diagnosis, were assessed. Results: The mucosal antibody was IgA-predominant. In the NELF of asymptomatic paediatric patients, S1-specific IgA was induced as early as the first four days post-diagnosis. Their plasma S1-specific IgG levels were higher than in symptomatic patients in the second week after diagnosis. The IgA and IgG levels correlated positively with the surrogate neutralization readout. The detectable NELF “receptor-blocking” S1-specific IgA in the first week after diagnosis correlated with a rapid decline in viral load. Conclusions: Early and intense nasal S1-specific IgA levels link to a rapid decrease in viral load. Our results provide insights into the role of mucosal immunity in SARS-CoV-2 exposure and protection. There may be a role of NELF IgA in the screening and diagnosis of SARS-CoV-2 infection.
- Published
- 2022
- Full Text
- View/download PDF
4. Inferring the Association between the Risk of COVID-19 Case Fatality and N501Y Substitution in SARS-CoV-2
- Author
-
Shi Zhao, Jingzhi Lou, Marc K. C. Chong, Lirong Cao, Hong Zheng, Zigui Chen, Renee W. Y. Chan, Benny C. Y. Zee, Paul K. S. Chan, and Maggie H. Wang
- Subjects
COVID-19 ,SARS-CoV-2 ,N501Y substitution ,B.1.1.7 lineage ,case fatality ,statistical modelling ,Microbiology ,QR1-502 - Abstract
As COVID-19 is posing a serious threat to global health, the emerging mutation in SARS-CoV-2 genomes, for example, N501Y substitution, is one of the major challenges against control of the pandemic. Characterizing the relationship between mutation activities and the risk of severe clinical outcomes is of public health importance for informing the healthcare decision-making process. Using a likelihood-based approach, we developed a statistical framework to reconstruct a time-varying and variant-specific case fatality ratio (CFR), and to estimate changes in CFR associated with a single mutation empirically. For illustration, the statistical framework is implemented to the COVID-19 surveillance data in the United Kingdom (UK). The reconstructed instantaneous CFR gradually increased from 1.0% in September to 2.2% in November 2020 and stabilized at this level thereafter, which monitors the mortality risk of COVID-19 on a real-time basis. We identified a link between the SARS-CoV-2 mutation activity at molecular scale and COVID-19 mortality risk at population scale, and found that the 501Y variants may slightly but not significantly increase 18% of fatality risk than the preceding 501N variants. We found no statistically significant evidence of change in COVID-19 mortality risk associated with 501Y variants, and highlighted the real-time estimating potentials of the modelling framework.
- Published
- 2021
- Full Text
- View/download PDF
5. Quantifying the effect of government interventions and virus mutations on transmission advantage during COVID-19 pandemic
- Author
-
Jingzhi Lou, Hong Zheng, Shi Zhao, Lirong Cao, Eliza LY Wong, Zigui Chen, Renee WY Chan, Marc KC Chong, Benny CY Zee, Paul KS Chan, Eng-kiong Yeoh, and Maggie H Wang
- Subjects
SARS-CoV-2 ,Public Health, Environmental and Occupational Health ,COVID-19 ,Infectious and parasitic diseases ,RC109-216 ,General Medicine ,virus activities ,g-measure ,Infectious Diseases ,Government ,Mutation ,Humans ,Original Article ,government interventions ,Public aspects of medicine ,RA1-1270 ,Pandemics - Abstract
Background: The coronavirus disease 2019 (COVID-19) pandemic has become a major public health threat. This study aims to evaluate the effect of virus mutation activities and policy interventions on COVID-19 transmissibility in Hong Kong. Methods: In this study, we integrated the genetic activities of multiple proteins, and quantified the effect of government interventions and mutation activities against the time-varying effective reproduction number Rt. Findings: We found a significantly positive relationship between Rt and mutation activities and a significantly negative relationship between Rt and government interventions. The results showed that the mutations that contributed most to the increase of Rt were from the spike, nucleocapsid and ORF1b genes. Policy of prohibition on group gathering was estimated to have the largest impact on mitigating virus transmissibility. The model explained 63.2% of the Rt variability with the R2. Conclusion: Our study provided a convenient framework to estimate the effect of genetic contribution and government interventions on pathogen transmissibility. We showed that the S, N and ORF1b protein had significant contribution to the increase of transmissibility of SARS-CoV-2 in Hong Kong, while restrictions of public gathering and suspension of face-to-face class are the most effective government interventions strategies.
- Published
- 2022
- Full Text
- View/download PDF
6. Superspreading potential of SARS-CoV-2 Delta variants under intensive disease control measures in China
- Author
-
Shi Zhao, Zihao Guo, Marc Ka Chun Chong, Daihai He, and Maggie H Wang
- Subjects
China ,SARS-CoV-2 ,COVID-19 ,Humans ,General Medicine - Abstract
Given the heterogeneity in individual transmissibility, we estimated the superspreading potential of SARS-CoV-2 Delta variants. Using case series of Delta variants in Guangdong, China, we found 15% (95%CrI: 12, 19) of cases seeded 80% of offspring cases.
- Published
- 2022
7. A tentative assessment of the changes in transmissibility and fatality risk associated with Beta SARS-CoV-2 variants in South Africa: an ecological study
- Author
-
Shi Zhao, Zhihang Peng, and Maggie H. Wang
- Subjects
South Africa ,Infectious Diseases ,SARS-CoV-2 ,Public Health, Environmental and Occupational Health ,Commentary ,COVID-19 ,Humans ,Parasitology ,General Medicine ,Microbiology ,Pandemics - Abstract
The circulation of SARS-CoV-2 Beta (B.1.351) variants challenged the control of COVID-19 pandemic. The numbers of COVID-19 cases and deaths and SARS-CoV-2 sequences in South Africa were collected. We reconstructed the variant-specified reproduction numbers (R t) and delay-adjusted case fatality ratio (CFR) to examine the changes in transmissibility and fatality risk of Beta over non-Beta variants. We estimated that Beta variants were 41% (95%CI: 16, 73) more transmissible and 53% (95%CI: 6, 108) more fatal than non-Beta variants. Higher risks of infection and fatality might lead to increasing volumes of infections and critical patients.
- Published
- 2021
8. The co-circulating transmission dynamics of SARS-CoV-2 Alpha and Eta variants in Nigeria: A retrospective modeling study of COVID-19
- Author
-
Shi Zhao, Salihu S Musa, Marc KC Chong, Jinjun Ran, Mohammad Javanbakht, Lefei Han, Kai Wang, Nafiu Hussaini, Abdulrazaq G Habib, Maggie H Wang, and Daihai He
- Subjects
Likelihood Functions ,SARS-CoV-2 ,Health Policy ,Public Health, Environmental and Occupational Health ,COVID-19 ,Humans ,Nigeria ,Pandemics ,Retrospective Studies ,Research Theme 1: COVID-19 Pandemic - Abstract
Background The COVID-19 pandemic poses serious threats to public health globally, and the emerging mutations in SARS-CoV-2 genomes has become one of the major challenges of disease control. In the second epidemic wave in Nigeria, the roles of co-circulating SARS-CoV-2 Alpha (ie, B.1.1.7) and Eta (ie, B.1.525) variants in contributing to the epidemiological outcomes were of public health concerns for investigation. Methods We developed a mathematical model to capture the transmission dynamics of different types of strains in Nigeria. By fitting to the national-wide COVID-19 surveillance data, the transmission advantages of SARS-CoV-2 variants were estimated by likelihood-based inference framework. Results The reproduction numbers were estimated to decrease steadily from 1.5 to 0.8 in the second epidemic wave. In December 2020, when both Alpha and Eta variants were at low prevalent levels, their transmission advantages (against the wild type) were estimated at 1.51 (95% credible intervals (CrI) = 1.48, 1.54), and 1.56 (95% CrI = 1.54, 1.59), respectively. In January 2021, when the original variants almost vanished, we estimated a weak but significant transmission advantage of Eta against Alpha variants with 1.14 (95% CrI = 1.11, 1.16). Conclusions Our findings suggested evidence of the transmission advantages for both Alpha and Eta variants, of which Eta appeared slightly more infectious than Alpha. We highlighted the critical importance of COVID-19 control measures in mitigating the outbreak size and relaxing the burdens to health care systems in Nigeria.
- Published
- 2021
9. Attach importance of the bootstrap
- Author
-
Shi, Zhao, Zuyao, Yang, Salihu S, Musa, Jinjun, Ran, Marc K C, Chong, Mohammad, Javanbakht, Daihai, He, and Maggie H, Wang
- Subjects
Male ,serial interval ,Analysis of Variance ,China ,Original Paper ,Models, Statistical ,SARS-CoV-2 ,COVID-19 ,clinical epidemiology ,ROC Curve ,Area Under Curve ,Sample Size ,Humans ,natural sciences ,Female ,statistical hypothesis testing ,Bootstrap t test - Abstract
Student's t test is valid for statistical inference under the normality assumption or asymptotically. By contrast, although the bootstrap t test was proposed in 1993, it is seldom adopted in medical research. We aim to demonstrate that the bootstrap t test outperforms Student's t test under normality in data. Using random data samples from normal distributions, we evaluated the testing performance, in terms of true-positive rate (TPR) and false-positive rate and diagnostic abilities, in terms of the area under the curve (AUC), of the bootstrap t test and Student's t test. We explore the AUC of both tests with varying sample size and coefficient of variation. We compare the testing outcomes using the COVID-19 serial interval (SI) data in Shenzhen and Hong Kong, China, for demonstration. With fixed TPR, the bootstrap t test maintained the equivalent accuracy in TPR, but significantly improved the true-negative rate from the Student's t test. With varying TPR, the diagnostic ability of bootstrap t test outperformed or equivalently performed as Student's t test in terms of the AUC. The equivalent performances are possible but rarely occur in practice. We find that the bootstrap t test outperforms by successfully detecting the difference in COVID-19 SI, which is defined as the time interval between consecutive transmission generations, due to sex and non-pharmaceutical interventions against the Student's t test. We demonstrated that the bootstrap t test outperforms Student's t test, and it is recommended to replace Student's t test in medical data analysis regardless of sample size.
- Published
- 2021
10. The non-pharmaceutical interventions may affect the advantage in transmission of mutated variants during epidemics: A conceptual model for COVID-19
- Author
-
Shi Zhao, Kai Wang, Marc K.C. Chong, Salihu S. Musa, Mu He, Lefei Han, Daihai He, and Maggie H. Wang
- Subjects
Statistics and Probability ,General Immunology and Microbiology ,SARS-CoV-2 ,Applied Mathematics ,Modeling and Simulation ,COVID-19 ,Humans ,General Medicine ,Models, Theoretical ,Epidemics ,General Agricultural and Biological Sciences ,Pandemics ,General Biochemistry, Genetics and Molecular Biology - Abstract
As the COVID-19 pandemic continues, genetic mutations in SARS-CoV-2 emerge, and some of them are found more contagious than the previously identified strains, acting as the major mechanism for many large-scale epidemics. The transmission advantage of mutated variants is widely believed as an innate biological feature that is difficult to be altered by artificial factors. In this study, we explore how non-pharmaceutical interventions (NPI) may affect transmission advantage. A two-strain compartmental epidemic model is proposed and simulated to investigate the biological mechanism of the relationships among different NPIs, the changes in transmissibility of each strain and transmission advantage. Although the NPIs are effective in flattening the epidemic curve, we demonstrate that NPIs probably lead to a decline in transmission advantage, which is likely to occur if the NPIs become intensive. Our findings uncover the mechanistic relationship between NPIs and transmission advantage dynamically, and highlight the important role of NPIs not only in controlling the intensity of epidemics but also in slowing or even containing the growth of the proportion of variants.
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.